Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss
- 1 November 1994
- journal article
- clinical trial
- Published by Springer Nature in Osteoporosis International
- Vol. 4 (6) , 341-348
- https://doi.org/10.1007/bf01622195
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Low-dosage micronized 17ß-estradiol prevents bone loss inpostmenopausal womenAmerican Journal of Obstetrics and Gynecology, 1992
- Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopauseThe Lancet, 1991
- Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal womenThe Lancet, 1990
- Transdermal administration of oestrogen/progestagen hormone replacement therapyThe Lancet, 1990
- Hip Fracture and the Use of Estrogens in Postmenopausal WomenNew England Journal of Medicine, 1987
- Quantitative Computed Tomography of Vertebral Spongiosa: A Sensitive Method for Detecting Early Bone Loss After OophorectomyAnnals of Internal Medicine, 1982
- Postmenopausal osteoporosis.BMJ, 1982
- Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal femalesEuropean Journal of Clinical Investigation, 1980
- POST-MENOPAUSAL $OElig;STROGENS PROTECT AGAINST FRACTURES OF HIP AND DISTAL RADIUS A Case-control StudyThe Lancet, 1979
- LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGENThe Lancet, 1976